ANNOUNCEMENTS


June 13, 2019

Board Meeting-Outcome

Intimation that while considering the offer made by Dr. A. Velumani, Chairman, MD & CEO to acquire the Company’s shareholding in NHL, both the Audit Committee and the Board of Directors have unanimously decided that the Company has to determine whether it would be beneficial for the Company to hive off the subsidiary or retain it, and for this purpose, it would be advisable to obtain one more valuation report to ensure that the valuation of the subsidiary has been correctly ascertained. The Committee decided to appoint a SEBI approved merchant banker to submit a valuation report, within the shortest possible time, and then take a decision.  None of the Promoter-directors were present during the discussions.

June 12, 2019

Investor/Analyst Meeting

Intimation about the following forthcoming meetings:

(i) Meeting with the representative(s) of Sundaram Mutual Fund, at 10.30 A.M. on Saturday, June 15, 2019.

(ii) Meeting with the representative(s) of Reliance Mutual Fund, at 12.00 Noon on Saturday, June 15, 2019.

(iii) Meeting with the representative(s) of Banyan Capital Advisors LLP, at 10.00 A.M. on Wednesday, June 19, 2019.

(iv) Meeting with the representative(s) of Grandeur Peak Global Advisors, at 02.00 P.M. on Thursday, June 27, 2019.

June 10, 2019

Board Meeting

Intimation that a meeting of the Board of Directors will be held on Thursday, June 13, 2019, to discuss about the offer made by Dr. A. Velumani, Chairman, Managing Director & CEO to acquire the shareholding of the Company in Nueclear Healthcare Limited (NHL), the wholly owned subsidiary of the Company.

May 27, 2019

Investor/Analyst Meeting

Intimation about the following forthcoming meetings:

i) Meeting with the representative(s) of CWC Advisors, at 02.00 P.M. on Tuesday, May 28, 2019 at the Corporate Office of the Company.

ii) Meeting with the representative(s) of Mirabilis Investment Trust, at 04.00 P.M. on Wednesday, May 29, 2019 at the Corporate Office of the Company.

iii) Participation of our representative(s) at “Trinity India- 2019” Organized by Batlivala & Karani Securities India Pvt. Ltd. at Hotel Trident, BKC on Friday, May 31, 2019 from 10.00 A.M., where representatives of various fund houses would be met.

 

May 23, 2019

Investor/Analyst Con-call

Intimation that  the representative(s) of SAIF Partners would be having a Con-call with us by 3.00 P.M. on Thursday, May 23, 2019.

 

May 21, 2019

Investor/Analyst Meeting

Intimation about meeting of representative(s) of Anived Portfolio Managers Private Limited, with us at 02.00 P.M. on Wednesday, May 22, 2019 at the Corporate Office of the Company.

May 21, 2019

Business update

Intimation that we had participated in the tender floated by Municipal Corporation of Greater Mumbai (the “MCGM”) for outsourcing of laboratory investigative services “Aapli Chikitsa”, and we have  now received a  letter from MCGM informing us that our tender has been accepted by them; we have been  authorized to provide laboratory investigative services “Aapli Chikitsa” over  a period of 4 years from the commencement of operations, to the MCGM affiliated hospitals and clinics in Western Suburban Zone and City Zone  of Mumbai. The total contract cost of the tender to be executed over the period of 4 years is Rs. 532.27 million, with an assurance of about 60% of total samples test per year; we have since complied with the terms and conditions and are poised to commence the operation on tender awarded by Municipal Corporation of Greater Mumbai for availing laboratory investigative services “Aapli Chikitsa” within next 30 days.

May 21, 2019

Board Meeting-Update

Intimation that at the Board Meeting held on 18-05-2019, when the Auditors pointed out the impairment of investment in Nueclear Healthcare Limited (NHL), the wholly owned subsidiary, Dr. A. Velumani, Chairman, Managing Director & CEO has offered to buy the entire shareholding of the Company in NHL at the current investment value of Rs. 194.67 crores to ensure that there is no loss to the public shareholders; however, all required formalities will be complied with by the Company for such a transaction; we were waiting for the concurrence from the Auditors to intimate this and hence the delay.

 

May 20, 2019

Post-Result Conference Call

Intimation about conference call for Indian and Overseas Investors to be held on 21-05-2019 to discuss about Audited financial results (Stand-alone and Consolidated) for the quarter / full year ended 31-03-2019

Click here to see the invite

May 18, 2019

Board Meeting-Outcome

Intimation of decisions taken at the Board Meeting held on May 18, 2019, about approval of the Audited Financial Statements (both Stand-alone and Consolidated) for the quarter and the whole year ended 31-03-2019, Recommendation of a Dividend of Rs.20/- per share for 2018-19 and granting of Stock Options for employees for 2018-19.

May 3, 2019

Board Meeting

Intimation about Board Meeting scheduled to be held on Saturday, May 18, 2019 to inter alia, consider and approve the audited financial results (both Stand-alone and Consolidated) for the year ended  31st March 2019, to consider declaration of dividend, if any, and to consider issue of stock options to employees for 2018-19.

Intimation about closure of Trading Window for Directors, Employees and Connected Persons from April 26, 2019 (as already announced) up to end of the day on May 21, 2019.

April 30, 2019

Investor/Analyst Meeting

Intimation about meeting of representative(s) of SAIF Partners, with us at 10.00 A.M. on Thursday, May 02, 2019 at the Corporate Office of the Company, followed by a visit to our Lab.

April 26, 2019

Intimation – Closure of Trading Window

Intimation that Trading Window shall remain closed for Directors, Employees and Connected Persons from April 26, 2019 until 48 hours after announcement of the financial results for FY 2018-19. The actual date of re-opening of trading window will be notified in due course.

April 26, 2019

Intimation – Compliance of SEBI (D&P) Regulations 2018

Confirmation of compliance of provisions of Reg. 74(5) of SEBI (Depositories & Participants) Regulations 2018, as certified by the Company’s RTA

April 26, 2019

Intimation – SEBI Circular dated 26-11-2018

Intimation about non-applicability of framework for Fund Raising by issue of Debt Securities by Large Entities notified by SEBI

April 10, 2019

Investor/Analyst Meeting

Intimation that representative(s) of TA Associates, would be having a meeting with us at 2.30 P.M. on Thursday, April 11, 2019 at the Corporate Office of the Company, followed by a visit to our Lab.

 

April 3, 2019

Investor/Analyst Meeting

Intimation about the following analyst meetings to be held at our corporate office:

i) Meeting with the representative(s) of Arisaig Partners, at 03.00 P.M. on Friday, April 05, 2019, to be followed by a visit by them to our Lab.

ii) Meeting with the representative(s) of Edelweiss Securities Limited, at 3.30 P.M. on Friday, April 05, 2019, to be preceded by a visit by them to our Lab.

March 23, 2019

Investor/Analyst Meeting

Intimation about the following Analyst Meetings:

i) Meeting with the representative(s) of Sands Capital Management, at 12.30 P.M. on Monday, March 25, 2019 at the Corporate Office of the Company, followed by Lab Visit.

ii) Participation of our representative at 1st Annual Edition of “INDIA IDEATION CONFERENCE” Organized by Motilal Oswal at Hotel Grand Hyatt, Mumbai on Wednesday, March 27, 2019 from 9.00 A.M. to 6.00 P.M, where he will meet representatives of various fund houses.

iii) Meeting with the representative(s) of Goldman Sachs India Securities Ltd., at 3.30 P.M. on Friday, March 29, 2019 at the Corporate Office of the Company.

March 16, 2019

Investor/Analyst Meeting

Intimation about the following Analyst Meetings :

i) Meeting of the representative(s) of Way2Wealth, a Coffee Day Company, at 11.30 A.M. on Wednesday, March 20, 2019 at the Corporate Office of the Company.

ii) Meeting of the representative(s) of SAIF Partners, at 06.00 P.M. on Monday, March 25, 2019 at Hotel Grand  Hyatt, Mumbai.

March 9, 2019

Investor/Analyst Meeting

Intimation about the following Analyst Meetings / Con-call, to be held at our corporate office:

i) Con-call between us and the representatives of Motilal Oswal Mutual Fund, at 3.00 P.M. on Monday, March 11, 2019.

ii) Meeting of the representative(s) of Capital International, at 09.30 A.M. on Tuesday, March 12, 2019.

iii) Meeting of the representative(s) of Seven Canyons Advisors, at 10.00 A.M. on Wednesday, March 13, 2019.

March 9, 2019

Board Meeting-Outcome

Intimation about the outcome of the Board Meeting held on 09-03-2019 – Appointment of Dr. Indumati Gopinathan as an Independent Director for a period of five years with immediate effect.
February 25, 2019

Investor/Analyst Meeting

Intimation about the following analyst meetings to be held at our corporate office: 

i) Meeting of the representative(s) of TA Associates, at 10.00 A.M. on Tuesday, February 26, 2019.

ii) Meeting of the representative(s) of Haitong Securities India Private Limited, at 3.30 P.M. on Wednesday, February 27, 2019.

February 23, 2019

Investor/Analyst Meeting

Intimation about the following analyst meetings to be held at our corporate office: 

i) Meeting of the representative(s) of Lohia Securities Limited, at 11.00 A.M. on Monday, February 25, 2019.

ii) Meeting of the representative(s) of TR Capital, at 11.00 A.M. on Tuesday, February 26, 2019.

February 22, 2019

Post-script of the conference call

Post-script of the conference call of Indian and Overseas Investors held on 12-02-2019 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter /nine months ended 31-12-2018 Click here

February 20, 2019

Investor/Analyst Meeting

Intimation about the following analyst meetings to be held at our corporate office: 

i) Meeting of the representative(s) of Consortium Securities Private Limited, at 3.30 P.M. on Friday, February 22, 2019.

ii) Meeting of the representative(s) of Pragya Equities Private Limited, at 5.00 P.M. on Wednesday, February 27, 2019.

February 19, 2019

Investor/Analyst Meeting

Intimation about the following analyst meetings to be held at our corporate office:

i) Meeting of the representative(s) of Ambit Capital Private Limited, at 4.00 P.M. on Wednesday, February 20, 2019.

ii) Meeting of the representative(s) of InvesQ Equity Investment Advisor, at 11.00 A.M. on Thursday, February 21, 2019.

iii) Meeting of the representative(s) of India Ratings & Research Private Limited, a Fitch Group Company, at 4.00 P.M. on Thursday, February 21, 2019.

February 14, 2019

Investor/Analyst Meeting

Intimation that the representative(s) of  SAIF Partners would be having a meeting with us at 1.00 P.M. on Friday, February 15, 2019 at the Corporate Office of the Company.

February 13, 2019

Investor/Analyst Meeting

Intimation that the representatives of Kayne Anderson Rudnick Investment Management LLC, USA and Macquarie Capital Securities (India) Private Limited, would be having a meeting with us at 12.00 Noon on Thursday, February 14, 2019 at the Corporate Office of the Company.

February 12, 2019

Investor/Analyst Meeting

Intimation that representative(s) of SPARX Asset Management, would be having a one-to-one meeting with us at 2.30 P.M. on Tuesday, February 19, 2019 at the Corporate Office of the Company and would also visit our Central Processing Laboratory after the meeting.

February 11, 2019

Post-Result Conference Call

Intimation about conference call for Indian and Overseas Investors to be held on 12-02-2019 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter / nine months ended 31-12-2018.

Click here to see the Invite

February 9, 2019

Board Meeting-Outcome

Intimation about the outcome of the Board Meeting held on 09-02-2019 – Approval of unaudited financial results for the quarter / nine months ended 31-12-2018.

February 7, 2019

Investor/Analyst Meeting

Intimation that Dr. A. Velumani, Chairman, Managing Director & CEO, would be participating at ‘10th Eureka Conference- London’ organized by M/s. Motilal Oswal Financial Services Limited, at St James Court, A Taj Hotel, London on 11th and 12th February 2019, where representatives of various fund houses would be meeting him.

January 31, 2019

Investor/Analyst Meeting

Intimation that Dr. A. Velumani, Chairman & Managing Director, would be participating at ‘10th Enterprising India Investors’ Conference organized by M/s. IIFL- Institutional Equities, at Hotel Trident BKC, Mumbai, on Wednesday, 13th February 2019, where representatives of various fund houses would be meeting him, from 02.00 P.M to 6.00 P.M.

Intimation that Mr. Sachin Salvi, General Manager- Finance would be participating at ‘Build India, New India’ Investor Conference organized by M/s. Antique Stock Broking Limited, at Hotel Sofitel BKC, Mumbai, on Tuesday, 12th February 2019, where representatives of various fund houses would be meeting him, from 10.00 A.M to 2.00 P.M.

January 28, 2019

Board Meeting

Intimation about Board Meeting scheduled to be held on February 09, 2019 to inter alia, consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter / nine months ended  31st December 2018 and to consider declaration of interim dividend, if any.

Intimation about closure of Trading Window for Directors, Employees and Connected Persons from January 29, 2019 to February 12, 2019. (both days inclusive).

December 13, 2018

Investor/Analyst Meeting

Intimation that a team of Fund Managers and Research Analysts of Malabar Investments would be having a meeting with Dr. A. Velumani, Chairman, Managing Director & CEO, Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, Dr. Caesar Sengupta, Vice-President-Operations and Mr. Sachin Salvi, General Manager-Finance, at our office by 11.00 A.M. on Monday, December 17, 2018.

December 5, 2018

Investor/Analyst Meeting

Intimation that Ms. Alka Katiyar, Research Associate- Pharma Institutional Equities of IndiaNivesh Securities Limited would be having a meeting with Mr. Sachin Salvi, General Manager-Finance, at our office by 11.00 A.M. on Tuesday, December 11, 2018.

December 3, 2018

Investor/Analyst Meeting

Intimation that Mr. Robert Harvey and Mr. Taizo Ishida, Portfolio Managers of Matthews Asia would be having a meeting with  Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde,Deputy  General Manager- Finance at Hotel Trident, BKC by 09.00 A.M. on Wednesday, December 05, 2018.

December 3, 2018

Investor/Analyst Meeting

Intimation that Mr. Shrikant Akolkar, Senior Analyst- Pharma of IIFL Securities Limited would be having a meeting with Mr. Sachin Salvi,  General Manager-Finance, at our office by 11.00 A.M. on Tuesday, December 04, 2018.

December 1, 2018

Investor/Analyst Meeting

Intimation that Ms. Charvi Pandey, Analyst of Fidelity International would be having a meeting with Mr. Sachin Salvi, General Manager-Finance, at our office by 10.00 A.M. on Tuesday, December 11, 2018 and she will also visit our CPL after meeting.

December 1, 2018

Investor/Analyst Meeting

Intimation that Mr. Kalpesh Parekh, Vice President- Institutional Sales and Mr. Surajit Pal, Analyst of Prabhudas Lilladher Pvt. Ltd. would be having a meeting with Dr. Caesar Sengupta, Vice-President- Operations and Mr. Sachin Salvi, General Manager-Finance, at our office by 03.30 P.M. on Wednesday, December 05, 2018.

December 1, 2018

Investor/Analyst Meeting

Intimation that Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General Manager- Finance would be participating at B & K’s Investor Conference- Emergent India- 2018 organized by M/s. Batlivala & Karani Securities India Pvt. Ltd., at Hotel Trident BKC, Mumbai, on Wednesday, 5th December 2018, where the representatives of various Funds would be meeting, from 10.00 A.M to 6.00 P.M.

November 27, 2018

Investor/Analyst Meeting

Intimation that Mr. Navin Ramachandran, Fund Manager and Mr. V. Srinath, Senior Analyst of Bellwether Capital would be having a meeting with Mr. Sachin Salvi, General Manager-Finance, at our office by 02.30 P.M. on Wednesday, November 28, 2018.

November 15, 2018

Investor/Analyst Meeting

Intimation that Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General Manager- Finance would be participating at Annual C.H.A.M.P.S. Conference organized by M/s. Spark Capital Advisors (India) Private Limited, at Hotel Trident BKC, Mumbai, on Friday, 16th November 2018, where they would be meeting representatives of various Funds, between 10.00 A.M. and 2.00

November 15, 2018

Post-script of the conference call

Post-script of the conference call of Indian and Overseas Investors held on 12-11-2018 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter /half year ended 30-09-2018.View Here

November 15, 2018

Investor/Analyst Meeting

Intimation that Mr. Sachin Salvi, General Manager-Finance, would be participating at IDFC Securities Annual Investor Conference ‘The Stock called India’ organized by M/s. IDFC Securities Limited, at Hotel Grand Hyatt, Mumbai, on Wednesday, 21st November 2018, where he would be meeting various investors between 2.00 P.M and 6.00 P.M.

November 9, 2018

Post-Result Conference Call

Intimation about conference call for Indian and Overseas Investors to be held on 12-11-2018 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter / half year ended 30-09-2018.Click to see invite Here

November 3, 2018

Board Meeting-Outcome

Intimation about the outcome of the Board Meeting held on 03-11-2018 – Approval of unaudited financial results for the quarter/half year ended 30-09-2018 and approval of issue & allotment of 33,973 equity shares to eligible employees who have exercised the Options granted to them in 2015.

November 2, 2018

Investor/Analyst Meeting

Intimation that Mr. Suney Hindocha and Mr. Edward Lam, Fund Managers of Somerset Capital Management, UK, would be having a meeting with Dr. Caesar Sengupta, Vice-President-Operations, Mr. Sachin Salvi, General Manager-Finance and Mr. Anand Velumani, Director of our subsidiary company, Nueclear Healthcare Ltd., at our office by 9.30 A.M. on Thursday, November 22, 2018.

November 2, 2018

Investor/Analyst Meeting

Intimation that Mr. Stephen Farley, Managing Partner and Mr. Andrei Stetsenko, Partner of Farley Capital, New York would be having a meeting with Dr. Caesar Sengupta, Vice-President-Operations, Mr. Sachin Salvi, General Manager-Finance and Mr. Anand Velumani, Director of our subsidiary company, Nueclear Healthcare Ltd., at our office by 9.30 A.M. on Thursday, November 15, 2018.

October 25, 2018

Board Meeting

Intimation about Board Meeting scheduled to be held on November 03, 2018, to inter alia, consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter / half year ended 30th September 2018.

Intimation about closure of Trading Window for Directors, Employees and Connected Persons from October 25, 2018 to November 06, 2018 (both days inclusive).

October 3, 2018

Investor/Analyst Meeting

Intimation that Mr. Krishnakumar, CIO of Sundaram Mutual Fund would be having a con-call with our Chairman & Managing Director, Dr. A. Velumani on Friday, October 05, 2018, by 10.00 A.M.

August 30, 2018

Investor/Analyst Meeting

Intimation about meeting of Mr. Sunil Asnani, Portfolio Manager, of Matthews International Capital Management, with one or more of the following, viz. Mr. Anand Velumani, Dr. Caesar Sengupta, Vice President-Operations, Mr. Sachin Salvi, General Manager-Finance, and Mr. Vatsal Goyal, Head-Strategy & Corporate Development, at our office by 04.00 P.M. on Monday, September 10, 2018.

August 25, 2018

Investor/Analyst Meeting

Intimation about participation of Mr.Anand Velumani, and Mr. Aditya Shinde, Deputy General Manager-Finance in the Investor Conference organised by Motilal Oswal Securities Limited, at Hotel Grand Hyatt on Tuesday and Wednesday, August 28 and 29, 2018. View here

August 24, 2018

Investor/Analyst Meeting

Intimation about meeting of Mr. Kalpraj Dharamshi, Promoter of Dharamshi Securities Private Limited & Valuequest Investment Advisors P.Ltd., with our Chairman, Managing Director and CEO, Dr. A. Velumani, at our office by 11.30 A.M. on Friday, September 07, 2018.

August 24, 2018

Investor/Analyst Meeting

Intimation that Mr. Masahiro Kanezaki , Portfolio Manager of Portfolia Japan, who would meet our Chairman, Managing Director & CEO, Dr.A. Velumani on 06-09-2018, is a client of Kim Eng Securities India P. Ltd., and not part of Maybank, as earlier reported by us.

August 24, 2018

Investor/Analyst Meeting

Intimation about meeting of Mr. Apurv Kulkarni, Senior Analyst of Nine Rivers Capital Holdings Pvt. Ltd., with Dr. Caesar Sengupta, Vice-President-Operations, Mr. Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head- Strategy and Corporate Development, at our office by 2.00 P.M. on Tuesday, August 28, 2018.

August 18, 2018

Post-script of the conference call

Post-script of the conference call of Indian and Overseas Investors held on 14-08-2018 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter ended 30-06-2018. View Here

August 18, 2018

Investor/Analyst Meeting

Intimation about meeting of Mr. A. N. Seshadri, Principal and Mr. Gaurav Kothari, Fund Manager of Nalanda Capital, with our Chairman, Managing Director & CEO, Dr. A. Velumani and other key managerial personnel, at our office from 2.30 P.M. on Tuesday, August 21, 2018.

August 14, 2018

Investor/Analyst Meeting

Intimation about meeting of Mr. Masahiro Kanezaki, Portfolio Manager of Portfolia Japan, a part of Maybank, Malaysia, with our Chairman, Managing Director & CEO, Dr. A. Velumani, at our office by 9.30 A.M. on Thursday, September 06, 2018.

August 13, 2018

Intimation about Conference Call

Intimation about conference call of Indian and Overseas Investors to be held on 14-08-2018 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter ended 30-06-2018.

August 13, 2018

Investor/Analyst Meeting

Intimation about meetings of the following with our Chairman & Managing Director, Dr. A. Velumani, at our office tomorrow, 14th August 2018.
1. Mr. Dilip Bhat, Managing Director and Mr. Vishal Purohit, Head Equities of Prabhudas Lilladher by 2.00 P.M
2. Mr. Kahlil Randeria of New Horizon, by 4.00 P.M.

August 11, 2018

Board Meeting-Outcome

Intimation about approval of the Unaudited Financial Statements (both Stand-alone and Consolidated) for the quarter ended 30-06-2018 at the Board Meeting held on 11-08-2018.

August 7, 2018

Shareholders Meeting

Intimation that the 18th Annual General Meeting (originally scheduled to be held on 11-08-2018) has been postponed to 01-09-2018 due to unavoidable circumstances and administrative reasons, that formal notice will be sent to the shareholders separately, and that there is no change in book closure dates.

August 4, 2018

Board Meeting-Outcome

Intimation of Outcome of the Board Meeting held on August 04, 2018, (i. ) to approve a proposal of buy back of equity shares for a total amount of Rs. 63,00,00,000/- (Rupees sixty three crores) from existing shareholders (other than Promoters & Promoter group) at a maximum price of Rs. 730/- per share through Open Market route through stock exchanges and (ii) to postpone the 18th AGM convened for 11-08-2018 to be held on 01-09-2018.

August 3, 2018

Board Meeting

Intimation about Board Meeting scheduled to be held on August 11, 2018, to inter alia, consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter ended 30th June 2018.

July 28, 2018

Board Meeting

Intimation about Board Meeting scheduled to be held on August 04, 2018, to consider the proposal of buy back of equity shares and postponement of AGM convened to be held on 11-08-2018 to a later date.

Intimation about closure of Trading Window for employees, directors & connected persons, from July 30, 2018 to August 14, 2018 (both days inclusive).

July 17, 2018

Investor/Analyst Meeting

Intimation about the meeting of Mr. Sudarshan Padmanabhan, Research Analyst-Investment, of Sundaram Asset Management Company Limited, with our Chairman & Managing Director, Dr. A. Velumani, at our office by 12.00 Noon on Wednesday, July 18, 2018.

June 21, 2018

Investor/Analyst Meeting

Intimation about the meeting of Ms. Charulata Gaidhani and Mr. Milind Karmarkar, Research Analysts of Dalal & Broacha Stock Broking Pvt. Ltd., with our General Manger-Finance, Mr. Sachin Salvi and Head-Strategy and Corporate Development, Mr. Vatsal Goyal, at our office by 3.30 P.M. on Tuesday, 26th June 2018.

June 7, 2018

Investor/Analyst Meeting

Intimation about the meeting of Mr. Ashwin Reddy of Samatva Investments, with our General Manager-Finance, Mr. Sachin Salvi at our office by 11.00 A.M. on Friday, 08th June 2018.

May 23, 2018

Investor/Analyst Meeting

Intimation about the meeting of Ms.Roopa Raman of International Finance Corporation (IFC), with our General Manger-Finance, Mr. Sachin Salvi and Head-Strategy and Corporate Development, Mr. Vatsal Goyal, at our office by 11.00 A.M. today (Wednesday, 23rd May 2018).

May 9, 2018

Post-script of the conference call

Post-script of the conference call of Indian and Overseas Investors held on 03-05-2018 to discuss about audited financial results (stand-alone & consolidated) for the quarter/whole year ended 31-03-2018.View Here

May 8, 2018

Investor/Analyst Meeting

Intimation about the meeting of Mr. Sandip Patodia, Equity Analyst of Fundsmith LLP, with our Chairman & Managing Director, Dr. A. Velumani, General Manager- Finance, Mr. Sachin Salvi and Head- Strategy and Development, Mr. Vatsal Goyal, at our office by 10.30 A.M. on Wednesday, 06th June 2018, and his visit to our Lab in the morning before the meeting.

May 8, 2018

Investor/Analyst Meeting

Intimation about meeting of Mr. Vinod Jayaram, Senior Investment Analyst, of Elara Capital, with our General Manager- Finance, Mr. Sachin Salvi and Head- Strategy and Development, Mr. Vatsal Goyal, at our office by 11.00 A.M. on Thursday, 10th May 2018.

April 30, 2018

Post-Result Conference Call

Intimation about conference call of Indian and Overseas Investors to be held on 03-05-2018 to discuss about Audited financial results (Stand-alone and Consolidated) for the quarter/whole year ended 31-03-2018.

April 28, 2018

Board Meeting-Outcome

Intimation of decisions taken at the Board Meeting held on April 28, 2018, about approval of the Audited Financial Statements (both Stand-alone and Consolidated) for the quarter and the whole year ended 31-03-2018, Recommendation of Final Dividend of Rs.5/- per share and granting of Stock Options for employees for 2017-18, and other decisions taken at the Meeting.

April 10, 2018

Board Meeting

Intimation about Board Meeting scheduled to be held on April 28, 2018, to approve Audited financial results (Stand-alone and Consolidated) for the quarter/year ended 31-03-2018, to consider recommending final dividend, if any,for 2017-18 and to consider granting stock options to employees for 2017-18.

Intimation about Closure of Trading Window for employees, directors & connected persons, from April 11, 2018 to May 02, 2018.

March 29, 2018

Investor/Analyst Meeting

Intimation about meeting of Mr. Bharat Shah of ASK Wealth Management, with our Chairman & Managing Director, Dr. A. Velumani, at our office by 11.00 A.M. on Tuesday, 03rd April 2018.

March 17, 2018

Investor/Analyst Meeting

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani, with Mr. Nitin Bajaj of FIL India Business and Research Services Private Limited, at their office by 5.30 P.M. on Monday, 19 March 2018.

February 28, 2018

Investor/Analyst Meeting

Intimation about meeting of Mr. Kantor of Allard Partners, Hong Kong with Mr. Sachin Salvi, General Manager-Finance, by 9.00 A.M. on Wednesday, March 14, 2018, at our office, and his visit to our Central Processing Laboratory prior to the meeting.

February 12, 2018

Post-script of the conference call

Post-script of the conference call of Indian and Overseas Investors held on 09-02-2018 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter/nine months ended 31-12-2017. View Here

February 8, 2018

Post-Result Conference Call

Intimation about conference call of Indian and Overseas Investors to be held on 09-02-2018 to discuss about unaudited financial results (stand-alone and consolidated) for the quarter/nine months ended 31-12-2017.

February 3, 2018

Board Meeting-Outcome

Intimation of decisions taken at the Board Meeting held on February 03, 2018, about approval of the Unaudited Financial Statements (both Stand-alone and Consolidated) for the quarter and nine months ended 31-12-2017, as per IND-AS Standards and other decisions taken at the Meeting.

Intimation of declaration of interim dividend of Rs.5/- per share for FY 2017-18, and fixing of Friday, February 16, 2018 as the Record Date for this purpose.

January 27, 2018

Board Meeting

Intimation about Board Meeting scheduled to be held on February 03, 2018, to approve unaudited financial results (Stand-alone and Consolidated) for the quarter/nine months ended 31-12-2017.

Intimation about closure of trading window for employees, directors & connected persons from 29-01-2018 to 05-02-2018 (both days inclusive).

December 15, 2017

Post-script of the conference call

Post-script of the conference call of Indian and Overseas Investors held on 12-12-2017 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter/half year ended 30-09-2017.View Here

December 11, 2017

Post-Result Conference Call

Intimation about conference call of Indian and Overseas Investors to be held on 12-12-2017 to discuss about unaudited financial results (stand-alone and consolidated) for the quarter/half year ended 30-09-2017.

December 9, 2017

Board Meeting-Outcome

Intimation of decisions taken at the Board Meeting held on December 09, 2017, about approval of the Unaudited Financial Statements (both Stand-alone and Consolidated) for the quarter ended 30-09-2017, as per IND-AS Standards and other decisions taken at the Meeting.

November 24, 2017

Board Meeting

Intimation about Board Meeting scheduled to be held on December 09, 2017 to approve unaudited financial results (Stand-alone and Consolidated) for the quarter/half year ended 30-09-2017 and to consider declaring interim dividend.

Intimation about closure of trading window for employees, directors & connected persons from 27-11-2017 to 11-12-2017 (both days inclusive).

November 8, 2017

Investor/Analyst Meeting

Intimation that Mr. Silas Xu, Founding Partner and Mr. Tushar Mallo, Partner of Ishana Capital, a newly formed long/short equity hedge fund based in Hong Kong, would be having a meeting with our Vice-President, Dr. Caesar Sengupta, General Manager-Finance, Mr. Sachin Salvi, and Head- Strategy and Development, Mr. Vatsal Goyal, by 4.15 P.M. on Friday, November 10, 2017, at our office.

September 16, 2017

Investor/Analyst Meeting

Intimation about con-call arranged by Edelweiss between Mr. Arnab Nandi, Portfolio Manager of Oxbow Capital and our General Manager- Finance, Mr. Sachin Salvi, on Wednesday, September 20, 2017.

September 15, 2017

Investor/Analyst Meeting

Intimation about meeting of analysts / representatives of different fund houses with Mr. Sachin Salvi,General Manager-Finance and/or Mr. Vatsal Goyal, Head – Strategy & Development, at different timings on the 18th, 19th and 21st September, 2017, at our office.

September 7, 2017

Investor/Analyst Meeting

Intimation about meeting of analysts / representatives of different fund houses with Mr. Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head – Strategy & Development, between 2.00 P.M.and 5.00 P.M. on Thursday, September 07, 2017, at our office.

September 5, 2017

Investor/Analyst Meeting

Intimation about meeting of Mr. Rakesh Nayudu, Analyst- Healthcare, of Haitong Securities India Private Limited, and his team with Mr. Sachin Salvi, General Manager-Finance, by 10.00 A.M. on Friday, September 08, 2017, at our office.

September 5, 2017

Investor/Analyst Meeting

Intimation about participation of Mr.Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head – Strategy & Development, in the Investor Conference organised by Motilal Oswal Securities Limited, at Hotel Grand Hyatt on Wednesday, September 06, 2017.

August 18, 2017

Change in Board of Directors

Intimation about change in the Board of Directors, i.e. appointment of Dr. Indumati Gopinathan as a Director in the place of Mr. Sohil Chand, the retiring director, who had expressed his intention not to seek reappointment.

August 18, 2017

Post-Result Conference Call

Intimation about the post-quarterly results conference call scheduled to be held at 3.00 p.m. on Monday,21-08-2017.

August 17, 2017

Shareholders Meeting

An update of the 17th Annual General Meeting of the Company held on 12-08-2017 and the resolutions passed thereat.

August 12, 2017

Board Meeting-Outcome

Intimation about decisions taken at the Board Meeting held on August 12, 2017, about approval of the Unaudited Financial Statements (both Stand-alone and Consolidated) for the quarter ended 30-06-2017, as per IND-AS Standards.

August 5, 2017

Board Meeting

Intimation about Board Meeting scheduled to be held on August 12, 2017 to approve unaudited financial statements (both Stand-alone and Consolidated) for the quarter ended June 30, 2017.

August 5, 2017

Shareholders Meeting

Intimation about notice received from a shareholder proposing appointment of Dr. Indumati Gopinathan as a Director in the place of Mr. Sohil Chand, the director liable to retire at the ensuing AGM to be held on 12-08-2017, who has expressed his intention not to seek reappointment.

July 22, 2017

Shareholders Meeting

Intimation about 17th Annual General Meeting convened to be held on 12-08-2017 at 10.30 A.M. , Book-Closure for payment of final dividend of Rs.5/- (on approval by shareholders), & e-voting facility available to the Shareholders.

June 28, 2017

Investor/Analyst Meeting

Intimation about meeting of Mr. Naveen Baid, Senior Analyst and Mr. Avinash Nahata, Head-Fundamental Equity Desk, of Aditya Birla Money Ltd., and their team with our General Manager-Finance, Mr. Sachin Salvi, by 4.00 P.M. on Thursday, June 29, 2017, at our office.

June 26, 2017

Investor/Analyst Meeting

Intimation about meeting of:
(i)Mr. Eric Jones, Portfolio Manager of Dragoneer Investment Group, U.S., with our Head (Strategy and Corporate Development), Mr. Vatsal Goyal, by 2.00 P.M. on Tuesday, June 27, 2017, at our office. The meeting is arranged by J M Financial Institutional Securities Ltd., Mumbai.
(ii)Mr. Vikas Gattani, CIO (based in Singapore) of Progress India Opportunities Fund, Mumbai, with our Vice-President (Operations), Dr. Caesar Sengupta and Head (Strategy and Corporate Development), Mr. Vatsal Goyal, by 9.30 A.M. on Wednesday, June 28, 2017, at our office.

June 20, 2017

Investor/Analyst Meeting

Intimation about: Meeting of Mr. H. Sangameswar Iyer, V.P. Investments, Shubhkam Ventures, with our General Manager-Finance, Mr. Sachin Salvi, and Head – Strategy & Corporate Development, Mr. Vatsal Goyal, by 11.00 A.M. on Wednesday, June 21, 2017, at our office.

June 17, 2017

Investor/Analyst Meeting

Intimation about: Meeting of Mr. Lukas Davies, Barca Capital USA, with our Vice-President, Dr. Caesar Sengupta, General Manager-Finance, Mr. Sachin Salvi, and Mr. Vatsal Goyal, Head – Nueclear Operations, by 10.00 A.M. on Monday, June 19, 2017, at our office.

June 14, 2017

Investor/Analyst Meeting

Intimation about:
Meeting of one Group of Investor with our Chairman & Managing Director, Dr. A. Velumani, by 10.00 A.M., at our office on Thursday, June 15, 2017, arranged by New Horizon Fund; and
Meeting of the following investors with our Chairman & Managing Director, Dr. A. Velumani in the afternoon, arranged by Centrum at their office.

Click to view Fund Details and Representative meetings

Fund Representatives Designation Time slot Meeting format
HDFC MF Prashant Jain,

Chirag Dagli

CIO,Senior Analyst 3.00-3.50 pm One on one
Reliance MF Saliesh Bhan,

Shrey Loonker

Deputy CIO,

Fund Manager

4.00-4.50 pm One on one
PNB Metlife Amit Shah Fund Manager 5.00-6.00 pm Group
HSBC MF Aditya Khemani Fund Manager 5.00-6.00 pm Group
IL & FS Suhas Naik Sr Fund Manager 5.00-6.00 pm Group
Reliance Life Suraj Makhija Fund Manager 5.00-6.00 pm Group

June 12, 2017

Intimation about Revised Financial Statement

Intimation that as the final dividend is subject to approval of members, the provision made therefor has been revised, resulting in increase of Rs.323.30 Million in Reserves & Surplus and decrease of similar amount from Short-term provisions. The revised Audited Financial Statements (both Stand-alone and Consolidated), are provided under Financial Statements.

June 7, 2017

Investor/Analyst Meeting

Intimation about meetings of
Mr. Sudarshan Padmanabhan, Analyst, Sundaram Mutual Fund, with our Vice-President, Dr. Caesar Sengupta, General Manager-Finance, Mr. Sachin Salvi, and Mr. Vatsal Goyal, Head–Nueclear Operations, by 10.00 A.M. on Thursday, June 08, 2017, at our office.
Mr. Thomas Mobille, Director/Senior Analyst, Limiar Capital Management, USA, with our General Manager-Finance, Mr. Sachin Salvi, and Mr. Vatsal Goyal, Head–Nueclear Operations, by 4.00 P.M. on Thursday, June 08, 2017, at our office.

June 6, 2017

Investor/Analyst Meeting

Intimation about Mr. Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head – Nueclear Operations, participating at an investor conference organized by M/s. Batlivala & Karani Securities India Pvt. Ltd., at Hotel Trident, BKC, on 7th June 2017, where the following fund managers will participate.

Click to View Fund Details

Fund Fund Rep Type of Meeting Time
HDFC Standard Life Hitesh Mahida One 9:00-9:45

June 3, 2017

Investor/Analyst Meeting

Intimation about meeting of the representatives of various funds, as follows, with our Chairman & Managing Director, Dr. A. Velumani, scheduled to take place from 5th to 8th June 2017, during his visit to Hong Kong and Singapore

Click to view Fund Details and Representative meetings

Date City Name of the Fund and the Representative meeting our CMD
5-Jun-17 Hong Kong Ward Ferry Management – Vineet Mitera & Piyush Maheshwari
Blackrock – Anand Agarwal
Manulife Asset Management – Linda Csellak
Capital World – Stephen Hui
Invesco
6-Jun-17 Hong Kong Janchor Partners – Wei Zhang
Indus Capital – Prasoon Agarwal
Hillhouse Capital
HSBC Asset Management – Elina Fung
JP Morgan – Karan Sikka
7-Jun-17 Singapore Blackstone Real Estate – Prashant Kanodia
Truston Asset Management – Hong Ig Ahn
Nikko Asset Management Asia Limited – Anuja munde, Ashwin Sanketh
Tokia Marine Asset Management – Arjya Chattoraj
Mitsubishi UFJ Trust & Banking Corporation – Ernest Sutanto
Eastspring Investments (Singapore) Limited – Gaurav Pathak
Alliance Bernstein (Singapore) Limited – Aadil Ebrahim
Daiwa SB Investments (Singapore) Limited – Joseph Ho
Lombard Odier Darier Hentsch Bank Switzerland – Odile Lange – Broussy
Manulife Asset Management Singapore – Koushik Pal, Rana Gupta
8-Jun-17 Singapore Affin Hwang Asset Management Berhad – Angie Tan, David Ng
Asian Islamic Investment Management SDN BHD – Paul Yong Rajan
Comgest FAR East Limited – Manish Shah
Intellective Capital PTE Limited – Nilesh Thakkar
Maybank Asset Management Singapore PTE Limited – Christina Hee
NN Investment Partners Asia Pacific – Kannan Venkataramani
Nomura Asset Management Singapore Limited – Poornaa Venkatesan, Vipin Kapoor
Fullerton Asset Management – Saurabh Chugh

May 22, 2017

Investor/Analyst Meeting

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani, in an investor conference on 30th May, 2017 at Hotel Sofitel, BKC, Mumbai, an open session attended by global / domestic institutional investors / fund houses, etc., being arranged by Phillip Capital.

May 10, 2017

Post-Result Conference Call

Intimation about conference call on 11-05-2017 about the Audited financial results for the quarter / whole year ended March 31, 2017

May 9, 2017

Board Meeting-Outcome

Intimation about decisions taken at the Board Meeting held on May 09, 2017, about approval of the Audited Financial Statements (both Stand-alone and Consolidated), Granting of Stock Options to the Employees for the FY 2016-17 and recommending a final dividend of Rs.5/- per share, which is in addition to the interim dividend of Rs. 5/- already paid. With this, the total dividend for the year would be 100%.

May 2, 2017

Board Meeting

Intimation about Board Meeting scheduled to be held on May 09, 2017 to approve audited financial statements (both Stand-alone and Consolidated) for FY 2016-17 and to consider granting of Stock Options to eligible employees for FY 2016-17.

April 22, 2017

Investor/Analyst Meeting

Intimation about meeting of the representatives of various funds, as follows, with our Chairman & Managing Director, Dr. A. Velumani, scheduled to take place on 26th & 27th April 2017 during his visit to UK.

Click to View Fund Details

DATE FROM NAME OF THE FUND AND THE REPRESENTATIVE MEETING OUR CMD
26-Apr-17 11.30 – 12.30 Natasha Ebtehadj, Columbia Threadneedle
26-Apr-17 14.00 – 15.00 Alex Markillie, USS Investment
26-Apr-17 15.30 – 16.30 Aimee Truesdale, Jupiter Asset
26-Apr-17 17.15 – 18.15 Hilary Natoff, FIL Ltd. UK.
27-Apr-17 09.45 – 10.45 Christopher Clube, Pioneer
27-Apr-17 11.30 – 12.30 Ben Hall, Mondrian
27-Apr-17 13.00 – 14.00 Venkatesh Sanjeevi, Pictet
27-Apr-17 15.00 – 16.00 Zafar Ahmadullah, Theleme Partners
27-Apr-17 16.30 – 17.30 Ambika Kapoor, GSA Capital

April 8, 2017

Investor/Analyst Meeting

Intimation about meeting of Mr. Mahesh Natarajan of ICICI Securities and Mr. Shriraam Rathi, ISec Healthcare Research Analyst, with our Chairman & Managing Director, Dr. A. Velumani on Monday, April 10, 2017 by 9.30 a.m. at our office.

Intimation about meeting of Analysts from Falcon Edge, Comgest, Goldman Sachs, PineBridge, East Bridge and a few other Investors, with our Chairman & Managing Director, Dr. A. Velumani on Monday, April 10, 2017 by 11.00 a.m., followed by a visit to our central Processing Laboratory at Navi Mumbai.

April 5, 2017

Investor/Analyst Meeting

Intimation about meeting of Mr. Anmol Ganjoo, of J M Financial, with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Friday, April 07, 2017, by 10.00 A.M.

March 27, 2017

Investor/Analyst Meeting

Intimation about meeting of Mr. Abhishek Thepade, Fund Manager of DNB Nor, with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Wednesday, March 29, 2017 by 10.00 A.M

March 24, 2017

Board Meeting-Outcome

Intimation about the following decisions taken at the Board Meeting held on March 24, 2017, subject to approval of Members wherever necessary:
(i) To reappoint Dr. A. Velumani as Managing Director & CEO for 3 years from 01-04-2017 on a token salary of Re. 1/- per month as chosen by him.
(ii) To reappoint Mr. A. Sundararaju as Executive Director & CFO for 3 years from 01-04-2017 on the same salary of Rs. 5 lakhs per month.
(iii) To acquire the trademark “Whaters” from Dr. A. Velumani, Chairman & Managing Director, who offered to assign the same to the Company for a token consideration of Re. 1/- and the trademark “Nueclear” to NHL, the wholly owned subsidiary, for a similar token consideration of Re. 1/-, and also waive the royalty due to him from both the companies for usage till now.
(iv) To give loan to NHL, the wholly owned subsidiary, at arm’s length basis, to help them acquire costly equipment like Cyclotron, PET-CT Scan machines, etc. for setting up additional scanning centres.

March 21, 2017

Investor/Analyst Meeting

Intimation about meeting of Mr. Rahul Gupta, Investment Analyst, of Fidelity International, with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Thursday, March 23, 2017 by 10.30 A.M.

March 8, 2017

Investor/Analyst Meeting

Intimation about change in timing of Conference Call between Mr. Anubhav Aggarwal, Healthcare Analyst from Credit Suisse and our General Manager- Finance, Mr. Sachin Salvi, on Wednesday, March 08, 2017 as 3.30 P.M., where some other analysts/investors might also join.

March 7, 2017

Investor/Analyst Meeting

Intimation about a Conference Call between Mr. Anubhav Aggarwal, Healthcare Analyst from Credit Suisse and our General Manager- Finance, Mr. Sachin Salvi, on Wednesday, March 08, 2017 by 11.00 A.M.

February 23, 2017

Investor/Analyst Meeting

Intimation about meeting of Mr. Kahlil Randeria and his team from New Horizon Funds, India, with our Chairman & Managing Director, Dr. A. Velumani, by 05.00 P.M. on Wednesday, March 01, 2017, at our Corporate Office.

February 22, 2017

Investor/Analyst Meeting

Intimation about meeting of Mr. Owens Huang, Asia Specialist & Co-Portfolio Manager from Dalton Investment, US, with our Vice-President (Operations), Dr. Caesar Sengupta, and General Manager-Finance, Mr. Sachin Salvi, at our Corporate Office, on Tuesday, February 28, 2017 by 03.00 P.M.

February 22, 2017

Investor/Analyst Meeting

Intimation about meeting of Mr. Anup Maheshwari, CIO & Head of Equities of DSP Blackrock, and his team, with our Chairman & Managing Director, Dr. A. Velumani, at our Corporate Office, on Monday, February 27, 2017 by 12.00 Noon.

February 16, 2017

Investor/Analyst Meeting

Intimation about meeting of Mr. Dushyant Sahani, Associate, of Samena Capital Investments Limited, Dubai, with our Vice President (Operations) Dr. Caesar Sengupta and General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, on Tuesday, February 21, 2017 by 03.00 PM and a likely meeting with our Chairman & Managing Director, Dr. A. Velumani too, subject to his availability.

February 14, 2017

Investor/Analyst Meeting

Intimation about meeting of Mr. Atul Mehra, Senior Analyst, and Mr. Prateek, of Motilal Oswal Mutual Fund, with our General Manager-Finance, Mr.Sachin Salvi and the Marketing Team at our Corporate Office, on Wednesday, February 15, 2017 by 11.00 AM, and a likely visit to one of our franchisees thereafter.

February 7, 2017

Investor/Analyst Meeting

Intimation about meeting of Mr. Balvinder Singh, Analyst from Canara HSBC, with our Vice-President (Operations), Dr. Caesar Sengupta and General Manager-Finance, Mr. Sachin Salvi, at our office by 5.00 PM on 09-02-2017.

January 30, 2017

Post-Result Conference Call

Intimation about conference call on 31-01-2017 about the unaudited financial results for the quarter / nine-months ended December 31, 2016.

January 28, 2017

Board Meeting-Outcome

Intimation of Outcome of the Board Meeting held on January 28, 2017 .(i) To declare an interim dividend of Rs. 5/- per share and fixing of 09-02-2017 as record date for payment of dividend and (ii) To approve the unaudited financial results (Stand alone and Consolidated) for the quarter / nine months ended December 31, 2016.

January 24, 2017

Investor/Analyst Meeting

Intimation about meeting of Mr. Jack and Mr. Mohan of Stewart Investors, UK, with our Chairman & Managing Director, Dr. A. Velumani at our office by 3.00 PM on 08-02-2017.

January 19, 2017

Board Meeting

Intimation about Board Meeting scheduled to be held on January 28, 2017 to approve unaudited financial statements (both Stand-alone and Consolidated) for the quarter/nine months ended 31-12-2016, and consider paying interim dividend if any.

December 24, 2016

Investor/Analyst Meeting

Intimation about meeting of our General Manager-Finance, Mr. Sachin Salvi, with Mr.Shaleen Kumar of UBS Securities India, at our office by 10.00 A.M. on 26-12-2016.

December 19, 2016

Investor/Analyst Meeting

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Ms. Amisha Vora & Mr. Dilip Bhat, Joint Managing Directors, and Mr. Vishal & Mr. Shankar, Co-Heads-Equities, of Prabhudas Lilladher Pvt. Ltd. at our office by 3.00 P.M. on 22-12-2016.

December 13, 2016

Investor/Analyst Meeting

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Sandeep Kothari and Mr. Rahul Gupta, of Fidelity International at our office by 9.00 A.M. on 23-12-2016

December 12, 2016

Investor/Analyst Meeting

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani, in Spark Healthcare Conference 2016, in BKC, Mumbai on 13-12-2016.

December 6, 2016

Investor/Analyst Meeting

Intimation about meeting of our General Manager-Finance, Mr. Sachin Salvi, with Mr. Sarath Sathkumara, Managing Director, Taiyo Pacific Partners, USA, at our office, by 4.30 P.M. on 20-12-2016.

December 6, 2016

Investor/Analyst Meeting

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Arindam Bhattacharjee, Partner & Portfolio Manager, Mr. Paul Ballantyne, Partner & Portfolio Manager, and Mr. Sebastian Peters, Portfolio Manager of Genesis Investment Management Ltd., UK, at our office, by 9.00 A.M. on 13-12-2016.

December 1, 2016

Investor/Analyst Meeting

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Sunil Asnani, Portfolio Manager of Matthews Asia of Matthews International Capital Management LLC, at our Office, at Navi Mumbai by 9.30 A.M.on 08-12-2016.

December 1, 2016

Investor/Analyst Meeting

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Krishna Kumar, Portfolio Manager of Eastsprings Investments (Singapore) Ltd., a wholly owned subsidiary of Prudential Plc of UK, at Hotel Trident, BKC, Mumbai, by 8.00 A.M. on 07-12-2016.

November 12, 2016

Investor/Analyst Meeting

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani at the IDFC Annual Investor Conference at “The Taj Lands End”, Mumbai, on 16-11-2016 where he would talk briefly about the Company, its nature of business and growth, and would also meet various investors / analysts attending the conference.

November 1, 2016

Investor/Analyst Meeting

Intimation about meeting of analysts from Stewart Investors, UK, with our Chairman & Managing Director, Dr. A. Velumani on 02-11-2016 and visit of analysts from Phillip Capital (India) P. Ltd., to our Central Processing Laboratory at Navi Mumbai on 02-11-2016.

October 24, 2016

Post-Result Conference Call

Intimation about conference call on 25-10-2016 about the unaudited financial results for the quarter / half-year ended September 30, 2016.

October 24, 2016

Board Meeting-Outcome

Intimation about approval of the unaudited financial results – both Stand-alone and Consolidated – for the quarter / half-year ended September 30, 2016.

October 15, 2016

Board Meeting

Intimation about Board Meeting scheduled to be held on October 24, 2016, to approve unaudited financial statements (both Stand-alone and Consolidated) for the quarter/six months ended 30-09-2016.

September 28, 2016

Investor/Analyst Meeting

Intimation about meeting between a few investors / fund managers and our Chairman & Managing Director, Dr. A. Velumani, on Friday, September 30, 2016 at 9.00 A.M. at Hotel J W Marriott, Mumbai.

September 27, 2016

Investor/Analyst Meeting

Intimation about meeting between analysts from Ventura Capital with our General Manager-Finance, Mr. Sachin Salvi on Wednesday, September 28, 2016 at 11.00 A.M. at our office at Navi Mumbai.

September 26, 2016

Investor/Analyst Meeting

Intimation about meeting between a few analysts / fund managers and our Chairman & Managing Director, Dr. A. Velumani on Tuesday, September 27, 2016 at 4.00 P.M. at our Office at Navi Mumbai.

September 13, 2016

Shareholders Meeting

Intimation about the 16th Annual General Meeting held on September 12, 2016.

September 4, 2016

Investor/Analyst Meeting

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani in a conference organised by Nomura group in UK where he had one-to-one meeting with representatives of six global fund managers.

August 27, 2016

Board Meeting-Outcome

Intimation about decision taken at the Board Meeting held on 27-08-2016 regarding sale of shares held by the Company in Thyrocare International Holding Co., Mauritius, to a relative of the Promoters.

July 22, 2016

Board Meeting-Outcome

Intimation about approval of the unaudited financial results – both Stand-alone and Consolidated – for the quarter ended June 30, 2016.

July 15, 2016

Board Meeting

Intimation about Board Meeting scheduled to be held on July 22, 2016 to approve unaudited financial results (Stand-alone and Consolidated), for the quarter ended June 30, 2016.

June 23, 2016

Investor/Analyst Meeting

Intimation about Meeting of a few analysts / fund managers with our Chairman & Managing Director at the Company’s Corporate Office at 10.00 a.m. on 24-06-2016.

June 14, 2016

Post-Result Conference Call

Intimation about Conference call arranged by the Company on June 15, 2016 for Indian and Overseas Investors to discuss about the financial results of Quarter / Financial Year ended 31-03-2016.

June 11, 2016

Board Meeting-Outcome

Intimation about decisions taken at the Board Meeting held on June 11, 2016, about approval of the Financial Statements (both Stand-alone and Consolidated), Granting of Stock Options to the Employees for the FY 2015-16 and recommending a final dividend of Rs. 2.5 per share. This is in addition to two interim dividends of Rs. 3.75 each, totaling to Rs. 7.50 per share, already paid. With this, the total dividend for the year would be 100%.

June 4, 2016

Board Meeting

Intimation about Board Meeting scheduled to be held on June 11, 2016 to approve financial statements (both Stand-alone and Consolidated), consider granting of Stock Options to eligible employees for FY 2015-16 and consider recommending final dividend if any.

June 1, 2016

Investor/Analyst Meeting

Intimation about Participation by the Company’s Chairman & Managing Director, Dr. A. Velumani in an Investors Conference organized by M/s. Batlivala & Karani Securities India Pvt. Limited on June 03, 2016 at Hotel Trident, where the following Fund Managers will have a meeting with him.

Click to View Fund Details

FUND FUND REP TYPE OF MEETING
Polunin Capital Aditya Mehta One
ASK Investment Managers Prateek Agrawal Group
Canbank MF Yogesh Patil Group
DSP BLACKROCK MF Vinit Sambre Group
Goldman Sachs Dheeresh Pathak Group
JM MF Chaitanya Choksi Group
LIC MF Amit Kadam Group
Malabar Investment Rajat Mahajan Group
Novastar Vijay Angadi Group
SBI Life Insurance Miyush Gandhi Group
Sundaram MF Sudarshan Padmanabhan Group
UTI MF Parag Chavan Group
Flowering Tree Investment Management Pvt Ltd Rajneesh Jhawar Group
Allard Partners Vishal Shah Group
Reliance Asset Management (Singapore) Pte Ltd Sulabh Jhajharia Group
DSP BLACKROCK MF Atul Bhole Group
M3 Investment J Sheth Group
HDFC Standard Life Shailesh Dhamankar Group
Motilal Oswal AMC Ashish Thavkar Group
M3 Investment Shahbaz Bilakhia Group
M3 Investment Yasser Lakdawala Group
HSBC MF Gautam Bhupal Group
Tata Investments Shatayu Mehta Group
Taurus MF Sadanand Shetty Group
Kotak Mutual Fund Devender Singhal Group
BNP Paribas AMC Shreyash Devalkar Group
Canara HSBC Insurance Rajatdeep Singh Anand Group
Allard Partners Gokul Maheshwari Group
Sloane Robinson Balthazar Florentin-Lee Group
Sloane Robinson Geroge Robinson Group
Max Life Mihir Vora One
Max Life Rahul Ranjan One

May 23, 2016

Investor/Analyst Meeting

Intimation about Plant visit by Analyst/Institutional Investor (Ambit Capital P. Ltd.) followed by one-to-one meeting on May 24, 2016.

May 18, 2016

Investor/Analyst Meeting

Intimation about Plant visit by Analyst/Institutional Investor (Fidelity International) followed by one-to-one meeting on May 25, 2016.

 

Latest Press Releases/Advertisements :

Advertisement – Audited financial statement – Stand alone & Consolidated for quarter / full year ended March 31, 2019.View Here

Presentation – Audited Financial Results for the quarter / full year ended March 31, 2019. View Here

Press Release – Highlights of Audited Financial Results for the quarter / full year ended March 31, 2019.View Here

Advertisement – Announcement regarding Board Meeting to be held on May 18, 2019, to, inter alia, consider and approve Stand-alone and Consolidated Audited Financial Results of the Company for the financial year ended 31-03-2019, to consider recommending dividend, if any, for the financial year 2018-19 and to consider granting of Employees Stock Options for the financial year ended 31-03-2019. View Here

Advertisement – Unaudited financial statement – Stand alone & Consolidated – for quarter / nine months ended December 31, 2018. View here

Presentation – Unaudited Financial Results for the quarter / nine months ended 31-12-2018. Click here to view the Presentation

Advertisement – Announcement regarding Board Meeting to be held on February 09, 2019, to, inter alia, consider and approve unaudited financial results (Stand-alone and Consolidated) for the quarter / nine months ended 31-12-2018 and declaration of interim dividend, if any, View here

Advertisement – Unaudited financial statement – Stand alone & Consolidated – for quarter / half year ended September 30, 2018.View Here

Presentation – Unaudited Financial Results for the quarter / half year ended September 30, 2018. View Here

Press Release – Highlights of Unaudited Financial Results for the quarter / half year ended September 30, 2018.View Here

Advertisement – Revised Notice of 18th Annual General Meeting, remote E-Voting information and book closure.
View in English
View in Marathi

Presentation – Unaudited results of Quarter ended June 2018. View Here

Advertisement – Announcement regarding Board Meeting to be held on August 11, 2018, to, inter alia, consider and approve unaudited financial results (Stand-alone and Consolidated) for the quarter ended 30-06-2018.View Here

Advertisement – Notice of 18th Annual General Meeting, remote E-Voting information and book closure.
View in English
View in Marathi

Presentation – Audited results of Financial Year 2017-18. View Here

Advertisement – Audited financial statement – Stand alone & Consolidated for quarter / whole year ended March 31, 2018.View Here

Media Release – Highlights of Audited Results for the quarter / whole year ended March 31, 2018. View Here

Advertisement – Announcement regarding Board Meeting to be held on April 28, 2018, to approve Audited financial results (Stand-alone and Consolidated) for the quarter/year ended 31-03-2018, to consider recommending final dividend, if any,for 2017-18 and to consider granting stock options to employees for 2017-18.View Here

Advertisement – Investor Presentation on unaudited financial results for the quarter/nine months ended 31-12-2017. View here

Advertisement – Extract of Unaudited Consolidated/Standalone Financial Results for the Quarter and Nine months ended 31 December 2017.View Here

Advertisement – Announcement regarding Board Meeting to be held on February 03, 2018, to approve unaudited financial results (Stand-alone and Consolidated) for the quarter/nine months ended 31-12-2017.View Here

Press Release about Launch of Focus TB – The brand for Tuberculosis Testing Services through highly advanced technologies at an affordable cost.View Here

Advertisement – Extract of Unaudited Consolidated/Standalone Financial Results for the Quarter and Six months ended 30 September,2017
View Here

Advertisement – Investor Presentation on unaudited financial results for the quarter/half year 30-09-2017 View Here

Advertisement – Media release on unaudited financial results for the quarter/half year 30-09-2017 View Here

Advertisement – Announcement regarding Board Meeting to be held on December 09, 2017 to approve unaudited financial results (Stand-alone and Consolidated) for the quarter/half year ended 30-09-2017 and to consider declaring interim dividend. View Here

Advertisement – Unaudited financial statements – Consolidated / Stand-alone for quarter ended June 30, 2017.View Here

Advertisement – Announcement regarding Board Meeting to be held on August 12, 2017, to approve unaudited financial results (Stand-alone and Consolidated) for the quarter ended 30-06-2017. View Here

Advertisement – Intimation under Sec. 160 of the Companies Act, 2013 about notice received from a shareholder proposing appointment of Dr. Indumati Gopinathan as a Director in the place of Mr. Sohil Chand, the retiring Director, who has expressed his intention not to seek reappointment.
View Here

Advertisement – Notice of 17th Annual General Meeting, remote E-Voting information and book closure View in English

Advertisement – Notice of 17th Annual General Meeting, remote E-Voting information and book closure View in Marathi

Advertisement – Audited financial statements – Consolidated for quarter / financial year ended March 31, 2017.View Here

Presentation – Audited results of Financial Year 2016-17. View Here

Media Release – Highlights of Audited Results of financial year ended March 31, 2017. View Here

Advertisement – Announcement regarding Board Meeting to be held on May 09, 2017 for approval of financial statements for the year ended 31-03-2017.View Here

Advertisement – Extract of Unaudited Consolidated Financial Results for the Quarter/Nine months ended December 31, 2016.View Here

Advertisement – Announcement regarding Board Meeting to be held on January 28, 2017.View Here

Advertisement – Extract of Unaudited Consolidated Financial Results for the Quarter/Half Year ended September 30, 2016.View Here

Advertisement – Announcement regarding Board Meeting to be held on Oct 24th, 2016. View Here

Advertisement – Notice of 16th Annual General Meeting, remote E-Voting information and book closure.View in Marathi
View in English

Advertisement – Extract of Unaudited Consolidated Financial Results for the Quarter ended June 30, 2016.View Here

Advertisement – Announcement regarding Board Meeting to be held on July 22, 2016. View Here

Advertisement – Audited financial statement – Consolidated for quarter / financial year ended March 31, 2016.View Here

Advertisement – Announcement regarding Board Meeting to be held on June 11, 2016. View Here